English
Home > Products > (alphaS)-alpha-Aminobenzenebutanoyl

China (alphaS)-alpha-Aminobenzenebutanoyl Factory

We take pleasure in an extremely fantastic standing among the our prospects for our great product top quality, competitive cost and the finest support for (alphaS)-alpha-Aminobenzenebutanoyl,CAS NO 868539-98-4,868539-98-4,Carfilzomib intermediate,Carfilzomib advance intermediate, We generally offer most effective top quality merchandise and great assistance for the majority of enterprise users and traders . Warmly welcome to affix us, let's innovate together, and fly dreams.
(alphaS)-alpha-Aminobenzenebutanoyl, We focus on providing service for our clients as a key element in strengthening our long-term relationships. Our continual availability of high grade solutions in combination with our excellent pre-sale and after-sales service ensures strong competitiveness in an increasingly globalized market. We have been willing to cooperate with business friends from at home and abroad and create a great future together.

Related Products

Hot Products

  • 1-Boc-3-Azetidinone

    1-Boc-3-Azetidinone

    Product Name:1-Boc-3-azetidinone
    Molecular Formula:C8H13NO3
    Molecular Weight:171.19
    CAS Registry Number:398489-26-4
  • 1-Chloropentane

    1-Chloropentane

    Product Name:1-Chloropentane
    Molecular Formula:C5H11Cl
    Molecular Weight:106.59
    CAS Registry Number:543-59-9
  • Bexarotene

    Bexarotene

    Product Name:Bexarotene
    Molecular Formula:C24H28O2
    Molecular Weight;348.48
    CAS Registry Number;153559-49-0
  • Sodium bromide

    Sodium bromide

    Product Name:Sodium bromide
    Molecular Formula:NaBr
    Molecular Weight;102.89
    CAS Registry Number;7647-15-6
  • 4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine

    4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine

    Product Name:4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine
    Molecular Formula:C7H5ClF3N
    Molecular Weight:195.57
    CAS Registry Number:320-51-4
  • 3-Quinuclidinone hydrochloride

    3-Quinuclidinone hydrochloride

    Product Name:3-Quinuclidinone hydrochloride
    Molecular Formula:C7H12ClNO
    Molecular Weight:161.63
    CAS Registry Number:1193-65-3
  • Related Blog
  • Reviews

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept